Evidence map›Paper›PMID 37249867›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Profiling the Epigenetic Landscape of the Spermatogonial Stem Cell-Part 1: Epigenomics Assays.

Keren Cheng, John R McCarrey

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Keren ChengDepartment of Neuroscience, Developmental and Regenerative Biology, University of Texas at San Antonio, San Antonio, TX, USA.
John R McCarreyDepartment of Neuroscience, Developmental and Regenerative Biology, University of Texas at San Antonio, San Antonio, TX, USA. John.McCarrey@utsa.edu.
The University of Texas at San Antonio · USZhejiang University · CN

Funding

Mechanism Underlying the Transduction of Epimutations from the Soma to the Male GermlineP50HD098593 · NICHD · UNIVERSITY OF NEVADA RENO · PI ZHENG, HUI · 2019 to 2024
$7.2M
Epimutations in Offspring Produced by Assisted Reproductive Technologies (ART)R01HD078679 · NICHD · UNIVERSITY OF TEXAS SAN ANTONIO · PI MCCARREY, JOHN R, MEISSNER, ALEXANDER · 2014 to 2018
$3.1M
NICHD NIH HHS P50 HD098593NICHD NIH HHS R01 HD078679
6 · The paper itself

Abstract

Epigenomics encompasses analyses of a variety of different epigenetic parameters which, collectively, make up the epigenetic programming that dictates cell fate and function. Here, protocols are provided for four different epigenomic methods including whole-genome bisulfite sequencing (WGBS) to assess DNA methylation patterns, chromatin immunoprecipitation-sequencing (ChIP-seq) to assess genomic patterns of either specific histone modifications or bound transcription factors, the assay for transposase-accessible chromatin-sequencing (ATAC-seq) to assess genomic patterns of chromatin accessibility, and high-throughput chromosome conformation capture-sequencing (Hi-C-seq) to assess three-dimensional interactions among distant genomic regions, plus computational methodology to integrate data from those four methodologies using Chromatin State Discovery and Characterization (ChromHMM) to obtain the most comprehensive overall assessment of epigenetic programming.

Indexed as

ChromatinEpigenomicsEpigenesis, GeneticHigh-Throughput Nucleotide SequencingSequence Analysis, DNAStem CellsChromatinAssay for transposase-accessible chromatin-sequencing (ATAC-seq)Chromatin immunoprecipitation-sequencing (ChIP-seq)Chromatin State Discovery and Characterization (ChromHMM)Epigenomic profilingHigh-throughput chromosome conformation capture (Hi-C)Multiparametric integrative analysisWhole-genome bisulfite sequencing (WGBS)

Identifiers

PMID37249867
OpenAlexW4378746664

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.